These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1395074)

  • 1. An indirect evaluation of the effect of the autonomic nervous system following converting enzyme inhibition in hypertension.
    Asmar RG; Benetos A; Darne B; Laurent S; Safar ME
    Clin Exp Hypertens A; 1992; 14(5):853-73. PubMed ID: 1395074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nifedipine and enalapril on cardiac autonomic nervous function during the tilt test in elderly patients with hypertension.
    Okabayashi J; Matsubayashi K; Doi Y; Sato T; Ozawa T
    Hypertens Res; 1997 Mar; 20(1):1-6. PubMed ID: 9101305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of antihypertensive drugs on systolic blood pressure.
    Chaignon MM; Mourad JJ; Guédon J
    J Hypertens Suppl; 1993 Mar; 11(1):S27-31. PubMed ID: 8483018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
    Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of coronary flow reserve after long-term therapy with enalapril.
    Motz W; Strauer BE
    Hypertension; 1996 May; 27(5):1031-8. PubMed ID: 8621193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril.
    Milovanovic B; Trifunovic D; Djuric D
    Acta Physiol Hung; 2011 Mar; 98(1):71-84. PubMed ID: 21388933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
    Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
    Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril and autonomic reflexes and exercise performance.
    Reid JL; Millar JA; Campbell BC
    J Hypertens Suppl; 1983 Oct; 1(1):129-34. PubMed ID: 6100601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I; Omvik P; Jensen HA
    J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
    Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition.
    Mitchell GF; Lacourcière Y; Arnold JM; Dunlap ME; Conlin PR; Izzo JL
    Hypertension; 2005 Nov; 46(5):1111-7. PubMed ID: 16230523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.